Imunon, Inc.
IMNNHealthcare|Biotechnology|US
$0.84
-0.06 (-6.16%)
DCF Value
$3.07
Tangible Book / Share
$0.80
Cash / Share
$1.31
Clinical Trials (17)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06915025 Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer | Epithelial Ovarian Cancer, Ovarian Cancer | P3 | Recruiting | 500 | RCT, Open-label | IMNN-001 (IL-12 Plasmid Formulated with PEG-PEI-Cholesterol Lipopolymer), Paclitaxel, Carboplatin, Olaparib, Niraparib |
| NCT03393884 Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2) | Epithelial Ovarian Cancer, Fallopian Tube Cancer | P1P2 | Active | 130 | RCT, Open-label | IMNN-001, Carboplatin, Paclitaxel |
| NCT05739981 Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer | Ovarian Cancer, Fallopian Tube Cancer | P1P2 | Recruiting | 30 | RCT, Open-label | Paclitaxel, Carboplatin, Bevacizumab, IMNN-001 |
| NCT00617981 Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC) | Hepatocellular Carcinoma | P3 | Completed | 701 | RCT, Double-blind | ThermoDox, 5% Dextrose Solution |
| NCT02112656 Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC) | Hepatocellular Carcinoma | P3 | Completed | 554 | RCT, Double-blind | ThermoDox, Dummy infusion |
| NCT01464593 Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC) | Colon Cancer Liver Metastasis | P2 | Terminated | 2 | Open-label | Lyso-Thermosensitive Liposomal Doxorubicin, ThermoDox |
| NCT00036998 Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer | Breast Cancer | P2 | Unknown | — | RCT, Open-label | — |
| NCT01640847 MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases | Painful Bone Metastases, Breast Carcinoma | P2 | Withdrawn | — | Open-label | High Intensity Focused Ultrasound (HIFU) in combination with ThermoDox |
| NCT00826085 Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall | Breast Cancer | P1P2 | Completed | 17 | Open-label | ThermoDox in combination with Microwave Hyperthermia (heat) |
| NCT02850419 Heat-Activated Target Therapy of Local-Regional Relapse in Breast Cancer Patients | Breast Cancer | P2 | Withdrawn | — | Open-label | ThermoDox (Thermally Sensitive Liposomal Doxorubicin) |
| NCT00036985 Combination Chemotherapy With or Without Microwave Thermotherapy Before Surgery in Treating Women With Locally Advanced Breast Cancer | Breast Cancer | P2 | Unknown | — | RCT, Open-label | cyclophosphamide, doxorubicin hydrochloride |
| NCT06283459 Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2 | SARS CoV 2 Infection | P1P2 | Completed | 24 | Open-label | IMNN-101 |
| NCT02181075 Targeted Chemotherapy Using Focused Ultrasound for Liver Tumours | Liver Tumour | P1 | Completed | 10 | Open-label | ThermoDox® (LTLD) |
| NCT04852367 PanDox: Targeted Doxorubicin in Pancreatic Tumours | Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV | P1 | Withdrawn | — | Open-label | Doxorubicin, ThermoDox |
| NCT02480374 Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian Cancer | Epithelial Ovarian Cancer, Fallopian Tube Cancer | P1 | Completed | 18 | Open-label | IMNN-001 |
| NCT00441376 A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver | Hepatocellular Carcinoma, Liver Neoplasms | P1 | Completed | 30 | Open-label | ThermoDox |
| NCT00061867 Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer | Prostate Cancer | P1 | Completed | — | Open-label | pegylated liposomal doxorubicin hydrochloride |